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Abstract An optimized national resistance monitoring program should deliver a precise estimate
of the resistance situation for a given combination of bacteria and antimicrobial at a low cost. In
order to achieve this, decisions need to be made on the number of  samples to be collected at
each of different possible sampling points along the food production line. Sampling decisions do
not only depend on the prevalence of resistance and sensitivity and specificity of resistance test-
ing, but also on the prevalence of the bacteria, and test characteristics of isolation of these bacte-
ria. Our aim was to develop a stochastic simulation model that optimized a national resistance
monitoring program in pig production, taking multi-stage sampling, imperfect sensitivity and
specificity of diagnostic tests, and cost-effectiveness considerations into account.
Introduction The use of antimicrobial substances in animal production is one potential reason for
the occurrence of resistant bacteria in humans. Thus monitoring the resistance status of various
bacteria in the animal population is important for a timely intervention before resistant strains
spread throughout the animal population. Currently, Switzerland is developing the scientific basis
for the implementation of routine antimicrobial resistance monitoring in food producing animals.
Through research projects and pilot monitoring programs in various animals species, data on the
prevalence of selected bacteria and antimicrobial resistance are collected. Three major sources of
information are available for a comprehensive assessment of the resistance situation (figure 1).
The resistance situation in clinical isolates from diseased animals reflects resistance levels in
problem animals, and provides information on the effectiveness of common veterinary drugs for
the treatment of diseases on swine farms. Therefore, the focus of the resistance monitoring in
this group of animals should be on bacteria pathogenic to animals, as well as on zoonotic bacteria
such as Salmonella and Campylobacter. The resistance situation in bacteria isolates from healthy
animals and food of animal origin, on the other hand, reflects the potential exposure of humans to
resistant bacteria from animals. Finally, data on antimicrobial usage are crucial for establishing epi-
demiological links between treatment regimens in animals and changes in the resistance situation
in animals and humans.
Along the food production chain, various sampling points are conceivable for resistance moni-
toring in healthy animals including sow, weaner pig or finishing pig farms, at slaughter, and at
retail level. The optimal sampling point may differ depending on the targeted bacteria and antimi-
crobial resistance involved. When monitoring resistance of bacteria originating from live animals,
decisions need to be made on the number of farms monitored, the number of animals tested per
farm, the number of samples per animal, and the number of colonies that are submitted to sus-
ceptibility testing from each sample.
Furthermore, decisions on the age of the
tested animals need to be done. Market
weight finishing pigs represent the end of
the live animal production line. Besides
the abattoir and fresh pork, this may be
the best sampling point for estimating
the risk for consumers deriving from
resistant bacteria from food animal origin.
On the other hand, testing sows is of
interest as they remain on the farms for a
longer time period than finishing pigs.
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such as E. coli or Enteroccus spp. from
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Figure 1: Elements of a resistance monitoring
program along the pork production chain.
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sows may thus provide a more representative overview on the resistance situation. Finally, as the
majority of pigs receiving antimicrobial treatment are piglets (Arnold et al, 2004) they can be
regarded as a high risk subpopulation and should be included in a resistance monitoring as well.
While a lot of data on the resistance situation in Switzerland are available from different infor-
mation sources, the methodology of data collection has not yet been standardized. Furthermore,
at each of the different sampling points, samples were only collected selectively in one year, and
no longitudinal data are available. In order to establish a continuous monitoring of antimicrobial
resistance, decisions need to be made on the number of samples to collect at each sampling
point, the sampling interval, the bacteria and antimicrobials to be monitored. As resources are lim-
ited, efforts should be made to obtain a maximum explanatory power of the monitoring with mini-
mal cost for sample collection and analysis.
The objective of this project was the development of an optimized antimicrobial resistance
monitoring program in pigs in Switzerland. To achieve this goal, existing information on antimicro-
bial resistance and antimicrobial use in pork production was collected, and data entered into a
stochastic simulation model. Optimization was defined as allocating available resources to differ-
ent sampling points to obtain the maximum precision of the prevalence estimate for resistant
bacteria, given the financial constraints of the program.
Pilot Monitoring of Antimicrobial Resistance Data on the resistance situation of clinical isolates
of pigs in Switzerland were collected by Wissing et al. (2001). Through a collaboration of Swiss
laboratories, antimicrobial resistance data and isolates of important bacterial pathogens from ani-
mals were collected over a period of ten months. The resistance situation for various pathogens
was assessed, and differences between animal species could be shown.
In healthy animals, testing for antimicrobial resistance is performed in sows, weaner pigs, fin-
ishing pigs, at the abattoir, and in pork. The prevalence of antimicrobial resistance in E. coli,
Enterococcus spp., and Campylobacter spp. from sows and weaner pigs is currently assessed in
a research project at the University of Zurich. On 60 pig farms, pooled fecal samples were taken
from the floor of pens with sows and weaner pigs, respectively. Culture was performed using
standard laboratory methods. For resistance testing, disc diffusion and microdilution was per-
formed. 
In a study on the prevalence of the most important bacterial zoonoses in Swiss finishing pigs
and in pork (Ledergerber et al, 2003) fecal samples were collected on 88 farms from the floor of
pens with market weight finishing pigs. Samples were pooled according to Stege et al. (2000)
and cultured for Salmonella spp., Campylobacter spp., and Yersinia enterocolitica. Susceptibility of
isolated campylobacter strains was tested with disc diffusion. Campylobacter spp. were isolated
out of 91.5% of pooled fecal samples from finishing pigs. The percentage of resistant campy-
lobacter strains isolated from finishing pigs is shown in figure 2. Thirty-six (13.4%) out of 263
strains were susceptible for all tested antimicrobials. One hundred sixty-eight (63.9%) strains
were resistant against one or two antimicrobials, whereas 59 (22.4%) strains were resistant
against three or more of the antimicrobials tested. 
On retail level, 865 samples of fresh pork were taken from shops all over Switzerland. Samples
included cutlet, meat cut into strips, and minced meat. Pork samples were cultured for Salmonella
spp., Campylobacter spp., and Yersinia enterocolitica. On retail level, Campylobacter spp. prevalence
was much lower than on the farm. In two (0.2%) out of 865 samples of fresh pork meat campy-
lobacter was isolated. At the abattoir, fecal samples of 100 pigs will be collected in Summer 2005.
Samples will be cultured for E. coli,
Enterococcus spp., and Campylobacter
spp., and resistance testing will be per-
formed with the microdilution method.
Data on antimicrobial use in feed
were collected by Arnold et al. (2004).
Prescription patterns for medicated
feedstuffs for pigs were analyzed over
a period of four years and prescribed
daily doses were derived. The consumption of antimi-
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Figure 2: Percentage of resistant Campylobacter
strains isolated from finishing pigs.
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crobials through medication by farmers and veterinarians will be assessed in a survey among vet-
erinarians. In Switzerland, all antimicrobials except in-feed formulas are marketed by veterinary
practitioners. Use of antimicrobial growth promoters has been illegal in Switzerland since 1999,
and therefore does not need to be considered in the monitoring program.
Development of an Optimized Resistance Monitoring Program The data described above are
used to develop an optimized sampling plan for monitoring resistance. The influence of sampling
more farms compared to sampling more animals per farm on the prevalence estimate for antimi-
crobial resistance is analyzed by simulation modeling. Accounting for the costs, the number of
samples to be taken at the respective step in the production line is optimized. This will be the
basis for implementing a continuous resistance monitoring program for pigs and the other major
food animal species in Switzerland.
Data obtained from the preliminary resistance monitoring activity allowed for comparing the
prevalence of Campylobacter spp. and antimicrobial resistance among sows, weaning pigs, finish-
ing pigs, and pork. The resistance situation in commensal bacteria could be compared between
sows and weaning pigs. The most effective points along the production line for monitoring antimi-
crobial resistance can be defined by evaluating the explanatory power of the information collected
at each sampling point. To achieve this,  a Monte Carlo simulation worksheet was developed,
which models the effect of various sampling strategies on the precision of the estimate of the
resistance prevalence in Swiss pigs. For the development of the model, Microsoft Excel, an Excel
macro using Visual Basic programming language, and Palisade @RISK software were utilized. In
the model, herds were randomly sampled from the pig population. The number of positive pooled
samples in the animals sampled from one herd was simulated, taking the herd size and the with-
in-herd prevalence for each sampled herd into account. The number of true and false positive
samples detected by diagnostic testing was determined from a binomial distribution, with p=sen-
sitivity or p=1-specificity, respectively. Uncertain input parameters were also described using
probability distributions available in @RISK. Prevalence estimates were described by a beta distri-
bution. Expert opinion was modeled by a pert distribution. A partial budget approach was utilized
to find the most cost-effective combination of samples to obtain a defined precision of the preva-
lence estimate.
Results of the model will allow the design of an optimized monitoring program for antimicro-
bial resistance in the Swiss pork production. As more data becomes available from continuous
monitoring of the resistance situation, this information will help to further refine the monitoring
program.
References
Arnold, S., Gassner, B., Giger, T., Zwahlen, R., 2004. Banning antimicrobial growth promoters in feedstuffs does not result in
increased therapeutic use of antibiotics in medicated feed in pig farming. Pharmacoepidemiol Drug Saf 13(5):323-31
Ledergerber, U., Regula, G., Danuser, J., Bissig-Choisat, B., Jemmi, T., Stärk, K.D.C., 2003. Prävalenz latenter Zoonoseereeger
in tierfreundlicher Schweineproduktion. Arch Lebensmittelhyg 54(4):90-94
Stege, H., Jensen, T.K., Moller, K., Baekbo, P., Jorsal, S.E., 2000. Prevalence of intestinal pathogens in Danish finishing pig
herds. Prev Vet Med 46:279-292
Wissing, A., Nicolet, J., Boerlin, P., 2001. The current antimicrobial resistance situation in Swiss veterinary medicine. Schweiz
Arch Tierheilkd 143(10):503-510
